课题基金 / 基金详情

LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES

LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES
通过二阴离子中间体制备木酚素抗肿瘤原型
批准号:
3179640
负责人:
JOHN L BELLETIRE
金额:
$6.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 1988-07-31

项目摘要

项目成果

JOHN L BELLETIRE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The specific goal of this proposal is the synthesis of a series of increasingly challenging lignan natural products culminating in the efficient preparation of two antitumor prototypes: steganacin and podophyllotoxin. Development of such sequences should prove especially useful for exploration of structure-activity relationships among analogs to these promising agents. Dianion intermediates exhibit extraordinary reactivity towards electrophiles. Preliminary studies have demonstrated that carboxylic acid dianions can be either dimerized or iodinated simply by varying the stoichiometry of added I2. Building upon this simple transformation, numerous symmetrically- and unsymmetrically-submitted succinic acid derivatives (including anhydrides, lactones, and amides) become readily available. Key synthetic steps to be explored in the generation of both steganacin and podophyllotoxin include reaction of amide dianions with 2-iodocarboxylates, selective reduction of the resulting acid-amide products, and intramolecular photochemically-driven iodination using N-iodoamide precursors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES
  • 批准号:
    3179644
  • 项目类别:
  • 资助金额:
    $5.28万
  • 财政年份:
    1985
  • 负责人:
    JOHN L BELLETIRE
  • 依托单位:
LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES
  • 批准号:
    3179643
  • 项目类别:
  • 资助金额:
    $4.43万
  • 财政年份:
    1985
  • 负责人:
    JOHN L BELLETIRE
  • 依托单位:
海外基金